Most pharmaceutical stocks rose, with Tongyuan Kangyi Medicine (02410) up 18.46%. Institutions pointed out that the policy trend of medical insurance funds supporting innovative drugs will not change.

Jingwu Cai Xun | Most pharmaceutical stocks rose, with Tongyuan Kang Medicine (02410) up 18.46%, Keji Pharmaceutical (02171) up 13.86%, Heyu (02256) up 11.79%, Cloud Peak Xin Yao (01952) up 10.31%, cansinobio (06185) up 7.48%. Zhong Yin International stated that benefiting from overseas interest rate cuts and domestic macroeconomic improvement, the pharmaceutical industry, as a high elasticity industry, is expected to outperform the market. The bank believes that the performance of the macroeconomy is closely related to the revenue and expenditure of medical insurance funds and medical health consumer spending. As policy focus shifts to stimulating the economy, the bank believes that medical industry

Golden Guardian Financial NewsNov 8 01:59 ET

BeiGene to Present at the Jefferies London Healthcare Conference

BusinesswireNov 6 06:01 ET

Express News | U.S.-Listed Shares of Chinese Firms Drop Premarket on Worries Over Growing U.S.-China Trade Tensions Under Trump Presidency

ReutersNov 6 04:27 ET

BeiGene to Share New Brukinsa Data at ASH Annual Meeting

TipRanksNov 5 09:15 ET

BeiGene Highlights Innovative Hematology Portfolio Across B-cell Malignancies at ASH 2024

BusinesswireNov 5 09:05 ET

Zymeworks Drops as Wells Fargo Cuts on Valuation

Seeking AlphaNov 1 11:20 ET